Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Extrawell Pharmaceutical Holdings PB Ratio?
Extrawell Pharmaceutical HoldingsHKSE:00858 -1.19% PB Ratio is 0.56 as of Sep. 21, 2026, which is 155% above its 10-year median of 0.22. The stock has 5 warning signs investors should review. Among 922 Drug Manufacturers companies, Extrawell Pharmaceutical Holdings ranks better than 89.7% on this metric.
HKSE:00858'
s PB Ratio Range Over the Past 10 Years
Min: 0.05 Med: 0.22 Max: 0.65
Current: 0.55
During the past 13 years, Extrawell Pharmaceutical Holdings's highest PB Ratio was 0.65. The lowest was 0.05. And the median was 0.22.
HKSE:00858's PB Ratio is ranked better than 89.7% of 922
companies
in the Drug Manufacturers industry
Industry Median: 2.015
vs HKSE:00858: 0.55
During the past 12 months, Extrawell Pharmaceutical Holdings's average Book Value Per Share Growth Rate was -73.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -35.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -13.60% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -3.40% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Extrawell Pharmaceutical Holdings was 41.10% per year. The lowest was -35.00% per year. And the median was 4.10% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Extrawell Pharmaceutical Holdings PB Ratio Related Terms
Extrawell Pharmaceutical Holdings PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Extrawell Pharmaceutical Holdings's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Extrawell Pharmaceutical Holdings PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Extrawell Pharmaceutical Holdings's PB Ratio distribution charts can be found below:
* The bar in red indicates where Extrawell Pharmaceutical Holdings's PB Ratio falls into.
Extrawell Pharmaceutical Holdings PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Extrawell Pharmaceutical Holdings (HKSE:00858) has a PB Ratio of 0.56 as of Sep. 21, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Extrawell Pharmaceutical Holdings and its competitors. This is 155% above median its historical median of 0.22. Over the past decade, Extrawell Pharmaceutical Holdings' PB Ratio has ranged from 0.05 to 0.65. According to the industry distribution chart, Extrawell Pharmaceutical Holdings ranks #95 out of 922 companies in the Drug Manufacturers industry, placing it in the top 10.3%.
Is Extrawell Pharmaceutical Holdings' PB Ratio too high?
Extrawell Pharmaceutical Holdings' current PB Ratio of 0.56 is 155% above median its 10-year median of 0.22. Over the past 10 years, this metric has ranged from a low of 0.05 to a high of 0.65. The Drug Manufacturers industry median PB Ratio is 2.02. Extrawell Pharmaceutical Holdings' value of 0.56 is 72.2% below this industry median. Based on the distribution chart, Extrawell Pharmaceutical Holdings ranks #95 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Extrawell Pharmaceutical Holdings' PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Extrawell Pharmaceutical Holdings ranks #95 out of 922 companies for PB Ratio. This places Extrawell Pharmaceutical Holdings in the top 10% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.02. Extrawell Pharmaceutical Holdings' value of 0.56 is 72.2% below this benchmark. Historically, Extrawell Pharmaceutical Holdings' own PB Ratio has ranged from 0.05 to 0.65 over the past decade. While the company's 10-year median is 0.22 vs. the industry median of 2.02, Extrawell Pharmaceutical Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 2.02, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Extrawell Pharmaceutical Holdings's current PB Ratio of 0.56 is 72.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Extrawell Pharmaceutical Holdings and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Extrawell Pharmaceutical Holdings's current PB Ratio is 0.56, which is 155% above median its own 10-year median of 0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Extrawell Pharmaceutical Holdings stock overvalued right now?
Based on GuruFocus' analysis, Extrawell Pharmaceutical Holdings (HKSE:00858) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.05, compared to a current price of HK$0.08 — trading 66% above its estimated fair value. The current PB Ratio is 0.56, which is 155% above median its 10-year median of 0.22 and 72.2% below the Drug Manufacturers industry median of 2.02. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Extrawell Pharmaceutical Holdings (HKSE:00858), the current PB Ratio is 0.56 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Extrawell Pharmaceutical Holdings Ltd is an investment holding company. The company's operating segment includes Manufacturing, Trading, and Gene Development. It generates maximum revenue from the Manufacturing segment. The manufacturing segment is engaged in the development, manufacture, and sales of pharmaceutical products. Its trading segment is engaged in the marketing and distribution of imported pharmaceutical products. Geographically, it derives a majority of its revenue from China.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00858 has been successfully added to your 
